Stock DNA
Pharmaceuticals & Biotechnology
CNY 15,697 Million (Large Cap)
16.00
NA
1.62%
0.05
8.20%
1.75
Revenue and Profits:
Net Sales:
2,085 Million
(Quarterly Results - Jun 2026)
Net Profit:
283 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.51%
0%
20.51%
6 Months
15.13%
0%
15.13%
1 Year
12.73%
0%
12.73%
2 Years
68.61%
0%
68.61%
3 Years
10.73%
0%
10.73%
4 Years
15.69%
0%
15.69%
5 Years
-8.62%
0%
-8.62%
Zhejiang Hisun Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.87%
EBIT Growth (5y)
-1.79%
EBIT to Interest (avg)
4.41
Debt to EBITDA (avg)
2.51
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.78
Tax Ratio
32.28%
Dividend Payout Ratio
45.11%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.83%
ROE (avg)
6.61%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.31
EV to EBIT
12.62
EV to EBITDA
7.19
EV to Capital Employed
1.30
EV to Sales
1.18
PEG Ratio
0.49
Dividend Yield
2.16%
ROCE (Latest)
10.26%
ROE (Latest)
8.20%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
2,085.00
2,390.50
-12.78%
Operating Profit (PBDIT) excl Other Income
583.70
535.50
9.00%
Interest
12.00
16.70
-28.14%
Exceptional Items
-0.80
-0.40
-100.00%
Consolidate Net Profit
283.20
358.50
-21.00%
Operating Profit Margin (Excl OI)
167.90%
126.30%
4.16%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is -12.78% vs -9.00% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -21.00% vs 351.51% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
10,488.60
10,287.50
1.95%
Operating Profit (PBDIT) excl Other Income
2,079.90
1,837.20
13.21%
Interest
104.90
161.40
-35.01%
Exceptional Items
-223.60
-141.30
-58.24%
Consolidate Net Profit
547.50
591.30
-7.41%
Operating Profit Margin (Excl OI)
105.20%
72.50%
3.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.95% vs -0.41% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -7.41% vs 709.59% in Dec 2024
About Zhejiang Hisun Pharmaceutical Co., Ltd. 
Zhejiang Hisun Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






